1Globe Capital LLC - Jul 7, 2025 SCHEDULE 13D/A Report for SINOVAC BIOTECH LTD Common Shares, par value $0.001 per share (SVA)

Filing Manager: 1Globe Capital LLC
Reporting Manager: 1Globe Capital LLC
Security: SINOVAC BIOTECH LTD Common Shares, par value $0.001 per share
Symbol: SVA
Shares outstanding: 57.3M shares
Disclosed Ownership: 18.5M shares
Ownership: 32.3%
Form type: SCHEDULE 13D/A
Date filed: 7/7/2025, 09:41 PM
Date of event: Jul 7, 2025
Previous filing: Jul 3, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
1Globe Capital LLC	32.3%	18.5M	6.81M	11.7M	/s/ Chiang Li	Chairman	0001562189
1Globe Biomedical (Hong Kong) Company Limited	32.3%	18.5M	6.81M	11.7M	/s/ Chiang Li	Chairman